Alexander König is currently the HTA & Value Strategy Lead at Roche, where they oversee the GI cancer and NMD portfolio while leading initiatives in digital health. Previously, they served as Managing Director and Co-Founder at Curetics from 2017 to 2020. Alexander also worked at Roche as a Management Start-up Trainee, focusing on strategic pricing and reimbursement in Oncology. Their educational background includes a Bachelor of Science in Nutrition Science from Technische Universität München and two Master's degrees in Management, also from Technische Universität München and Hanken School of Economics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices